Document:

EXHIBIT
4.2

THE SECURITIES OFFERED INVOLVE A HIGH DEGREE
OF RISK AND MAY RESULT IN THE LOSS OF YOUR ENTIRE INVESTMENT. ANY PERSON CONSIDERING THE PURCHASE OF THESE SECURITIES SHOULD CONSULT WITH
HIS, HER OR ITS LEGAL, TAX AND FINANCIAL ADVISORS PRIOR TO MAKING AN INVESTMENT IN SECURITIES. THE SECURITIES SHOULD ONLY BE PURCHASED
BY PERSONS WHO CAN AFFORD TO LOSE ALL OF THEIR INVESTMENT.

 

SUBSCRIPTION AGREEMENT

 

This Subscription Agreement
(the “Agreement”), dated as of March 22, 2022 (the “Agreement”), is entered into by and between
the undersigned subscriber, (the “Subscriber”) and Evolutionary Genomics, Inc., a Nevada corporation (the “Company”).

WHEREAS, the Company is conducting
a “best efforts” offering (the “Offering”) up to $750,000 (the “Offering Amount”) of
Common Stock (the “Common Stock”);

 

WHEREAS, Subscriber desires to purchase
the Securities for the Purchase Price (as defined below), and the Company desires to sell the Common Stock to the Subscriber for the Purchase
Price.

 

NOW, THEREFORE, in consideration
of the mutual covenants and agreements herein contained, Subscriber and the Company agree as follows:

 

1.       Purchase
and Sale of the Securities.

 

(a)       The
Company hereby agrees to issue and to sell to Subscriber, and Subscriber hereby agrees to purchase from the Company, the Common Stock
as indicated above.

 

(b)       Upon
execution of this Agreement, Subscriber will deliver payment equal to the aggregate purchase price set forth on the signature page hereof
in an amount required to purchase and pay for the Common Stock subscribed for hereunder (the “Purchase Price”), which
amount has been paid in U.S. Dollars by wire transfer or check, subject to collection, to the order of “Evolutionary Genomics, Inc.”
The Purchase Price is the principal amount of the Common Stock, provided, however, the minimum amount of investment in the Common Stock
by each Subscriber shall be in the principal amount of $25,000, although the Company, in its sole discretion, may accept subscriptions
for less.

 

(c)       The
subscription amounts paid by the Subscriber to the Company will be deposited in the Company’s operating account. A closing shall
take place on such date and time specified by the Company. At the closing, the Company shall issue the Common Stock to the Subscriber.
The offering period will terminate upon the earlier to occur of (i) the date the Offering Amount is sold or (ii) June 30, 2022.

 

2.       Representations
and Warranties of Subscriber. Subscriber represents and warrants to the Company as follows:

 

(a)       Subscriber
is an “accredited investor” as defined by Rule 501 under the Act and Subscriber is capable of evaluating the merits and risks
of Subscriber’s investment in the Securities and has the ability and capacity to protect Subscriber’s interests.

 

    	1 

    	 

    

(b)       Subscriber
understands that the Common Stock has not been registered and will not be registered under the Act. Subscriber understands that the sale
of Common Stock to Subscriber will not be required to be registered under the Act on the ground that the issuance thereof is exempt under
Section 4(a)(2) of the Act as a transaction by an issuer not involving any public offering and that, in the view of the United States
Securities and Exchange Commission (the “SEC”), the statutory basis for the exception claimed would not be present
if any of the representations and warranties of Subscriber contained in this Subscription Agreement are untrue or, notwithstanding the
Subscriber’s representations and warranties, the Subscriber currently has in mind acquiring the Common Stock for resale upon the
occurrence or non-occurrence of some predetermined event.

 

(c)       Subscriber
acknowledges and understands that the Common Stock is being purchased for investment purposes and not with a view to distribution or resale,
nor with the intention of selling, transferring or otherwise disposing of all or any part thereof for any particular price, or at any
particular time, or upon the happening of any particular event or circumstances, except selling, transferring, or disposing the Common
Stock made in full compliance with all applicable provisions of the Act, the rules and regulations promulgated by the SEC thereunder,
and applicable state securities laws; and that an investment in the Securities is not a liquid investment.

 

(d)       Subscriber
acknowledges that the Common Stock must be held indefinitely unless subsequently registered under the Act or unless an exemption from
such registration is available. Subscriber is aware of the provisions of Rule 144 promulgated under the Act which permit limited resale
of a security subject to the satisfaction of certain conditions, including, among other things, the existence of a public market for the
security and the availability of certain current public information about the Company. In the event that the Company determines to register
the Securities under the Act, Subscriber agrees to cooperate with the Company as reasonably requested by the Company in connection with
the preparation and filing of a registration statement, unless such Subscriber notifies the Company in writing of Subscriber’s election
to exclude all of Subscriber’s Common Stock from the registration statement. Upon effectiveness of the registration statement, Subscriber
further agrees that it will comply with the prospectus delivery requirements of the Act as applicable to it in connection with sales of
their Common Stock pursuant to such registration statement.

 

(e)       Subscriber
acknowledges that Subscriber has had the opportunity to ask questions of and receive answers from the Company or any person acting on
its behalf concerning the Company and its business and to obtain any additional information, to the extent possessed by the Company (or
to the extent it could have been acquired by the Company without unreasonable effort or expense) necessary to verify the accuracy of the
information received by Subscriber. In connection therewith, Subscriber acknowledges that Subscriber has had the opportunity to discuss
the Company’s business, management and financial affairs with the Company’s management or any person acting on its behalf.
Subscriber has received and reviewed the Subscription Booklet, and all the information, both written and oral, that it desires. Without
limiting the generality of the foregoing, Subscriber has been furnished with or has had the opportunity to acquire, and to review, all
information, both written and oral, that it desires with respect to the Company’s business, management, financial affairs and prospects.
In determining whether to make this investment, Subscriber has relied solely on Subscriber’s own knowledge and understanding of
the Company and its business based upon Subscriber’s own due diligence investigations and the information furnished pursuant to
this paragraph. Subscriber understands that no person has been authorized to give any information or to make any representations which
were not furnished pursuant to this paragraph and Subscriber has not relied on any other representations or information.

 

    	2 

    	 

    

(f)       Subscriber
has all requisite legal and other power and authority to execute and deliver this Subscription Agreement and to carry out and perform
Subscriber’s obligations under the terms of this Subscription Agreement. This Subscription Agreement constitutes a valid and legally
binding obligation of Subscriber, enforceable in accordance with its terms, and subject to laws of general application relating to bankruptcy,
insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other general principals of
equity, whether such enforcement is considered in a proceeding in equity or law.

 

(g)       Subscriber
has carefully considered and has discussed with Subscriber’s professional legal, tax, accounting and financial advisors, to the
extent Subscriber has deemed necessary, the suitability of this investment and the transactions contemplated by this Subscription Agreement
for Subscriber’s particular federal, state, local and foreign tax and financial situation and has determined that this investment
and the transactions contemplated by this Subscription Agreement are a suitable investment for Subscriber. Subscriber relies solely on
such advisors and not on any statements or representations of the Company or any of its agents. Subscriber understands that Subscriber
(and not the Company) shall be responsible for Subscriber’s own tax liability that may arise as a result of this investment or the
transactions contemplated by this Subscription Agreement.

 

(h)       This
Subscription Agreement does not contain any untrue statement of a material fact concerning Subscriber.

 

(i)       There
are no actions, suits, proceedings or investigations pending against Subscriber or Subscriber’s properties before any court or governmental
agency (nor, to Subscriber’s knowledge, is there any threat thereof) which would impair in any way Subscriber’s ability to
enter into and fully perform Subscriber’s commitments and obligations under this Subscription Agreement or the transactions contemplated
hereby.

 

(j)       The
execution, delivery and performance of and compliance with this Subscription Agreement, and the issuance of the Common Stock will not
result in any material violation of, or conflict with, or constitute a material default under, any of Subscriber’s articles of incorporation
or bylaws, if applicable, or any of Subscriber’s material agreements nor result in the creation of any mortgage, pledge, lien, encumbrance
or charge against any of the assets or properties of Subscriber or the Common Stock.

 

(k)       Subscriber
acknowledges that the Common Stock is speculative and involve a high degree of risk and that Subscriber can bear the economic risk of
the purchase of the Common Stock, including a total loss of its investment.

 

(l)       Subscriber
fully understands that the proceeds from this Offering will be used for general working capital of the Company and research costs.

 

(m)       Subscriber
recognizes that no federal, state or foreign agency has recommended or endorsed the purchase of the Securities.

 

(n)       Subscriber
is aware that the shares of Common Stock is and will be, when issued, “restricted securities” as that term is defined in Rule
144 of the general rules and regulations under the Act.

 

    	3 

    	 

    

(o)       Subscriber
understands that any and all certificates representing shares of Common Stock and any and all securities issued in replacement thereof
or in exchange therefor shall bear the following legend or one substantially similar thereto, which Subscriber has read and understands:

 

“THE SECURITIES REPRESENTED BY
THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) AND ARE “RESTRICTED SECURITIES”
AS THAT TERM IS DEFINED IN RULE 144 UNDER THE ACT. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT, THE AVAILABILITY OF
WHICH IS TO BE ESTABLISHED TO THE REASONABLE SATISFACTION OF THE ISSUER.”

(p)       In
addition, the certificates representing shares of Common Stock, and any and all securities issued in replacement thereof or in exchange
therefor, shall bear such legend as may be required by the securities laws of the jurisdiction in which Subscriber resides.

 

(q)       Because
of the restrictions imposed on resale, Subscriber understands that the Company shall have the right to note stop-transfer instructions
in its stock transfer records, and Subscriber has been informed of the Company’s intention to do so. Any sales, transfers, or any
other dispositions of the Common Stock by Subscriber, if any, will be in compliance with the Act.

 

(r)       Subscriber
acknowledges that Subscriber has such knowledge and experience in financial and business matters that it is capable of evaluating the
merits and risks of an investment in the Common Stock and of making an informed investment decision.

 

(s)       Subscriber
represents that (i) Subscriber is able to bear the economic risks of an investment in the Common Stock and to afford the complete loss
of the investment; and (ii) (A) Subscriber could be reasonably assumed to have the capacity to protect its own interests in connection
with this subscription; or (B) Subscriber has a pre-existing personal or business relationship with either the Company or any affiliate
thereof of such duration and nature as would enable a reasonably prudent purchaser to be aware of the character, business acumen and general
business and financial circumstances of the Company or such affiliate and is otherwise personally qualified to evaluate and assess the
risks, nature and other aspects of this subscription.

 

(t)       Subscriber
understands that the Company shall have the unconditional right to accept or reject this subscription, in whole or in part, for any reason
or without a specific reason, in the sole and absolute discretion of the Company (even after receipt and clearance of Subscriber’s
funds). This Subscription Agreement is not binding upon the Company until accepted by an authorized officer of the Company. In the event
that the subscription is rejected, then Subscriber’s subscription funds will be returned without interest thereon or deduction therefrom.

 

(u)       Subscriber
has not been furnished with any oral representation or oral information in connection with the Offering of the Securities that is not
in this Subscription Booklet.

 

(v)       No
representations or warranties have been made to Subscriber by the Company, or any officer, employee, agent, affiliate or subsidiary of
the Company, other than the representations of the Company contained herein, and in subscribing for the Common Stock, Subscriber is not
relying upon any representations other than those contained in this Subscription Agreement.

 

    	4 

    	 

    

(w)Subscriber represents and
warrants, to the best of its knowledge, unless previously disclosed to the Company or its counsel, that no finder, broker, agent, financial
advisor or other intermediary, nor any purchaser representative or any broker-dealer acting as a broker, is entitled to any compensation
in connection with the transactions contemplated by this Subscription Agreement.

 

(x)       Subscriber
represents and warrants that he, she or it is not an affiliate of the Company.

 

(y)       Subscriber
understands that there is no minimum amount which must be raised before the Company holds an initial closing of this Offering.

 

3.       Representations, Warranties
and Covenants of the Company. The Company represents, warrants and covenants to Subscriber as follows:

 

(a)       The
Company is duly organized and validly existing as a corporation in good standing under the laws of Nevada.

 

(b)       The
Company has all such corporate power and authority to enter into, deliver and perform this Subscription Agreement.

 

(c)       All
necessary corporate action has been duly and validly taken by the Company to authorize the execution, delivery and performance of this
Subscription Agreement by the Company, and the issuance and sale of the Common Stock to be sold by the Company pursuant to this Subscription
Agreement. This Subscription Agreement has been duly and validly authorized, executed and delivered by the Company and constitutes the
legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as the enforceability
thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’
rights generally and by general equitable principles.

 

4.       Indemnification.
Subscriber agrees to indemnify and hold harmless the Company, its shareholders, officers, directors, employees, promissory noteholders
(if applicable) and affiliates, and any person acting on behalf of the Company, from and against any and all damage, loss, liability,
cost and expense (including reasonable attorneys’ fees and court costs) which any of them may incur by reason of the failure by
Subscriber to fulfill any of the terms and conditions of this Subscription Agreement, or by reason of any breach of the representations
and warranties made by Subscriber herein, or in any other document provided by Subscriber to the Company. All representations, warranties
and covenants of each of Subscriber and the Company contained herein shall survive the acceptance of this subscription.

 

5.       Miscellaneous.

 

(a)       Subscriber
agrees not to transfer or assign this Subscription Agreement or any of Subscriber’s interest herein and further agrees that the
transfer or assignment of the Common Stock acquired pursuant hereto shall be made only in accordance with all applicable laws.

 

(b)       Subscriber
agrees that Subscriber cannot cancel, terminate, or revoke this Subscription Agreement or any agreement of Subscriber made hereunder,
and this Subscription Agreement shall survive the death or legal disability of Subscriber and shall be binding upon Subscriber’s
heirs, executors, administrators, successors, and permitted assigns.

 

(c)       Subscriber
has read and has accurately completed this entire Subscription Agreement.

 

    	5 

    	 

    

(d)       This
Subscription Agreement constitutes the entire agreement among the parties hereto with respect to the subject matter hereof and may be
amended only by a written execution by all parties.

 

(e)       Subscriber
acknowledges that it has been advised to consult with its own attorney regarding this subscription and Subscriber has done so to the extent
that Subscriber deems appropriate.

 

(f)       Any
notice or other document required or permitted to be given or delivered to Subscriber shall be in writing and sent (i) by fax if the sender
on the same day sends a confirming copy of such notice by a recognized overnight delivery service (charges prepaid), or (b) by registered
or certified mail with return receipt requested (postage prepaid) or (c) by a recognized overnight delivery service (with charges prepaid).

 

If to the Company, at:

 

Evolutionary Genomics, Inc.

4220 Morning Star
Drive,

Castle Rock, Colorado 80108

Attention:
Steve B. Warnecke

or
such other address as it shall have specified to Subscriber in writing.

 

(g)       Failure
of the Company to exercise any right or remedy under this Subscription Agreement or any other agreement between the Company and Subscriber,
or otherwise, or delay by the Company in exercising such right or remedy, will not operate as a waiver thereof. No waiver by the Company
will be effective unless and until it is in writing and signed by the Company.

 

(h)       This
Subscription Agreement shall be enforced, governed and construed in all respects in accordance with the laws of the State of New York,
as such laws are applied by the New York courts to agreements entered into and to be performed in New York by and between residents of
New York, and shall be binding upon Subscriber, Subscriber’s heirs, estate, legal representatives, successors and assigns and shall
inure to the benefit of the Company, its successors and assigns.

 

(i)        If
any provision of this Subscription Agreement is held to be invalid or unenforceable under any applicable statute or rule of law, then
such provision shall be deemed modified to conform with such statute or rule of law. Any provision hereof that may prove invalid or unenforceable
under any law shall not affect the validity or enforceability of any other provisions hereof.

 

(j)        The
parties understand and agree that money damages would not be a sufficient remedy for any breach of the Subscription Agreement by the Company
or Subscriber and that the party against which such breach is committed shall be entitled to equitable relief, including injunction and
specific performance, as a remedy for any such breach. Such remedies shall not be deemed to be the exclusive remedies for a breach by
either party of the Subscription Agreement but shall be in addition to all other remedies available at law or equity to the party against
which such breach is committed.

 

(k)       All
pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine, singular or plural, as identity of
the person or persons may require.

 

(l)       This
Subscription Agreement may be executed in counterparts and by facsimile, each of which shall be deemed an original, but all of which shall
constitute one and the same instrument.

 

[Remainder of Page Intentionally Left Blank]

 

    	6 

    	 

    

IN WITNESS WHEREOF,
the parties have executed this Subscription Agreement as of the day and year first written above.

 

	$__________________________
	Aggregate Purchase Price

 

Manner in which Title is to be held (Please Check
One):

 

	1.	___	Individual	7.	___	Trust/Estate/Pension or Profit Sharing Plan

Date Opened:______________
	2.	___	Joint Tenants with Right of Survivorship	8.	___	As a Custodian for

________________________________

Under the Uniform Gift to Minors Act of the State of

________________________________
	3.	___	Community Property	9.	___	Married with Separate Property
	4.	___	Tenants in Common	10.	___	Keogh
	5.	___	Corporation/Partnership/ Limited Liability Company	11.	___	Tenants by the Entirety
	6.	___	IRA	12.	___	Foundation described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended.

 

IF MORE THAN ONE
SUBSCRIBER, EACH SUBSCRIBER MUST SIGN:

		1	INDIVIDUAL SUBSCRIBERS MUST COMPLETE PAGE 8

		2	SUBSCRIBERS WHICH ARE ENTITIES MUST COMPLETE PAGE 9

    	7 

    	 

    

EXECUTION BY NATURAL PERSONS

 

	
 

    Exact Name in Which Title is to be Held

     

	
    ___________________________________

    Name (Please Print)

     
	 	
    ___________________________________

    Name of Additional Subscriber

	
    ___________________________________

    Residence: Number and Street

     
	 	
    ___________________________________

    Address of Additional Subscriber

	
    ___________________________________

    City, State and Zip Code

     
	 	
    ___________________________________

    City, State and Zip Code

	
    ___________________________________

    Social Security Number
	 	
    ___________________________________

    Social Security Number

     

	
    ___________________________________

    Telephone Number
	 	
    ___________________________________

    Telephone Number

     

	
    ___________________________________

    Fax Number (if available)

     
	 	
    ___________________________________

    Fax Number (if available)

	
    ___________________________________

    E-Mail (if available)

     
	 	
    ___________________________________

    E-Mail (if available)

	
    ___________________________________

    (Signature)
	 	
    ___________________________________

    (Signature of Additional Subscriber)

	 	 	 
	*If Subscriber is a Registered Representative with a FINRA member firm, have the following acknowledgement signed by the appropriate party:	 
	The undersigned FINRA member firm acknowledges receipt of the notice required by Rule 3050 of the FINRA 

Conduct Rules	 
	 
	
     

    ___________________________________

    Name of FINRA Firm
	ACCEPTED this ____ day of __________ 2022, on behalf of Evolutionary Genomics, Inc.
	
     

    By: ________________________________

    Name:

    Title:
	
     

    By: ________________________________

    Name: Steve B. Warnecke

    Title: CEO

	 	 	 	 

 

    	8 

    	 

    

EXECUTION BY SUBSCRIBER WHICH IS AN ENTITY

(Corporation, Partnership, Trust, Etc.)

 

	
 

    Name of Entity (Please Print)

     

	Date of Incorporation or Organization:
	State of Principal Office:
	
    Federal Taxpayer Identification Number:

     

    ____________________________________________

    Office Address

    ____________________________________________

    City, State and Zip Code

    ____________________________________________

    Telephone Number

    ____________________________________________

    Fax Number (if available)

    ____________________________________________

    E-Mail (if available)

	
    

    [seal]

    

    Attest: ________________________________

    (If Entity is a Corporation)
	
    

    By: ________________________________

    Name:

                Title:

	 	 
	*If Subscriber is a Registered Representative with a FINRA member firm, have the following acknowledgement signed by the appropriate party:	 
	The undersigned FINRA member firm acknowledges receipt of the notice

required by Rule 3050 of the FINRA

Conduct Rules	 
	 
	
    

    ___________________________________

    Name of FINRA Firm
	ACCEPTED this ____ day of __________ 2022, on behalf of Evolutionary Genomics, Inc.
	
    

    By: ________________________________

    Name:

    Title:
	
    

    By: ________________________________

    Name: Steve B. Warnecke

    Title: CEO

 

 

9EX-4.5

 EXHIBIT 4.5 

DESCRIPTION OF SECURITIES 

Pursuant to our amended and restated certificate of incorporation, our authorized capital stock consists of 500,000,000 shares of Class A
common stock, $0.0001 par value, 100,000,000 shares of Class B common stock, $0.0001 par value, and 1,000,000 shares of undesignated preferred stock, $0.0001 par value. The following description summarizes the material terms of our capital
stock. Because it is only a summary, it may not contain all the information that is important to you. 
 Units 

Each unit consists of one share of Class A common stock and one-fifth of one redeemable warrant.
Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of  $11.50 per share, subject to adjustments as described set forth in the warrant agreement. Pursuant to the warrant agreement, a
warrant holder may exercise its warrants only for a whole number of shares of our Class A common stock. This means only a whole warrant may be exercised at any given time by a warrant holder. No fractional warrants have been issued upon
separation of the units and only whole warrants are traded. 
 The common stock and warrants constituting the units began separate trading
on April 5, 2021. 
 Common Stock 

As of March 31, 2022 a total of 69,000,000 shares of our common stock are outstanding, including: 

 

	 	•	 	 55,200,000 shares of our Class A common stock; and 

 

	 	•	 	 13,800,000 shares of Class B common stock held by Churchill Sponsor VI LLC (“sponsor”).

 Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by
stockholders. Holders of our Class B common stock will have the right to elect all of our directors prior to the consummation of our initial business combination; provided, however, that with respect to the election of directors in connection
with a meeting of the stockholders of the Company in which a business combination is submitted to the stockholders of the Company for approval, holders of the Class A common stock and holders of the Class B common stock, voting together as a single
class, shall have the exclusive right to vote for the election of directors. On any other matter submitted to a vote of our stockholders, holders of our Class B common stock and holders of our Class A common stock will vote together as a
single class, except as required by applicable law or stock exchange rule. These provisions of our amended and restated certificate of incorporation may only be amended by a majority of the Class B common stock then outstanding. Unless specified in
our amended and restated certificate of incorporation or bylaws, or as required by applicable law or stock exchange rules, the affirmative vote of a majority of our shares of common stock that are voted is required to approve any such matter voted
on by our stockholders (other than the election of directors). Directors are divided into three classes, each of which will generally serve for a term of three years with only one class elected in each year. There is no cumulative voting with
respect to the election of directors. In connection with our initial business combination, we may enter into a stockholder’s agreement or other arrangements with the stockholders of the target with respect to voting and other corporate
governance matters following completion of the initial business combination. Our stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor. 

Because our amended and restated certificate of incorporation authorizes the issuance of up to 500,000,000 shares of Class A common
stock, if we were to enter into a business combination, we may (depending on the terms of such a business combination) be required to increase the number of shares of common stock which we are authorized to issue at the same time as our stockholders
vote on the business combination to the extent we seek stockholder approval in connection with our initial business combination. 

  
 1 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
 In
accordance with the New York Stock Exchange (the “NYSE”) corporate governance requirements, we are not required to hold an annual meeting until not later than one year after our first fiscal year end following our listing on the NYSE.
Under Section 211(b) of the Delaware General Corporation Law (the “DGCL”), we are, however, required to hold an annual meeting of stockholders for the purposes of electing directors in accordance with our bylaws unless such election
is made by written consent in lieu of such a meeting. We may not hold an annual meeting of stockholders to elect new directors prior to the consummation of our initial business combination, and thus we may not be in compliance with
Section 211(b) of the DGCL, which requires an annual meeting. Therefore, if our stockholders want us to hold an annual meeting prior to the consummation of our initial business combination, they may attempt to force us to hold one by submitting
an application to the Delaware Court of Chancery in accordance with Section 211(c) of the DGCL. 
 We will provide our public
stockholders with the opportunity to redeem all or a portion of their shares upon the completion of our initial business combination at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two
business days prior to the consummation of our initial business combination, including interest (net of permitted withdrawals), divided by the number of then outstanding public shares, subject to the limitations described herein. The amount in the
trust account was initially $10.00 per public share. The per share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters. The redemption
right will include the requirement that any beneficial owner on whose behalf a redemption right is being exercised must identify itself in order to validly redeem its shares. Each public stockholder may elect to redeem its public shares without
voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. Our sponsor, officers and directors have each entered into a letter agreement with us, pursuant to which they have agreed to waive their
redemption rights with respect to any founder shares and any public shares held by them in connection with the completion of our initial business combination. Permitted transferees of our sponsor, officers or directors are subject to the same
obligations. Unlike many blank check companies that hold stockholder votes and conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of public shares for cash upon completion of such
initial business combinations even when a vote is not required by applicable law or stock exchange listing requirements, if a stockholder vote is not required by applicable law or stock exchange listing requirements and we do not decide to hold a
stockholder vote for business or other reasons, we will, pursuant to our amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”),
and file tender offer documents with the SEC prior to completing our initial business combination. Our amended and restated certificate of incorporation requires these tender offer documents to contain substantially the same financial and other
information about the initial business combination and the redemption rights as is required under the SEC’s proxy rules. If, however, a stockholder approval of the transaction is required by applicable law or stock exchange rules, or we decide
to obtain stockholder approval for business or other reasons, we will, like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If we
seek stockholder approval, unless a different vote is required by applicable law or stock exchange rules, we will complete our initial business combination only if a majority of the outstanding shares of common stock voted are voted in favor of the
business combination. Unless otherwise required by applicable law or stock exchange rules, a quorum for such meeting will consist of the holders present in person or by proxy of shares of outstanding capital stock of the company representing a
majority of the voting power of all outstanding shares of capital stock of the company entitled to vote at such meeting. However, the participation of our sponsor, officers, directors, advisors or any of their respective affiliates in
privately-negotiated transactions (as described in the initial public offering (“IPO”) prospectus)), if any, could result in the approval of our initial business combination even if a majority of our public stockholders’ vote, or
indicate their intention to vote, against such business combination. For purposes of seeking approval of the majority of our outstanding shares of common stock, non-votes will have no effect on the approval of
our initial business combination once a quorum is obtained. We intend to give approximately 30 days (but not less than 10 days nor more than 60 days) prior written notice of any such meeting, if required, at which a vote shall be taken to approve
our initial business combination. These quorums and voting thresholds and agreements may make it more likely that we will consummate our initial business combination. 

If we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our amended and restated certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in
concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended, or the “Exchange Act”), will be restricted from redeeming more than 

  
 2 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

 an aggregate of 15% of the shares sold in the IPO, without our prior consent, which we refer to as the
“Excess Shares.” However, we would not be restricting our stockholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Our stockholders’ inability to redeem the
Excess Shares will reduce their influence over our ability to complete our initial business combination, and such stockholders could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such
stockholders will not receive redemption distributions with respect to the Excess Shares if we complete the business combination. And, as a result, such stockholders will continue to hold that number of shares exceeding 15% and, in order to dispose
such shares would be required to sell their stock in open market transactions, potentially at a loss. 
 If we seek stockholder approval in
connection with our initial business combination, our sponsor, officers and directors have (and their permitted transferees, as applicable, will agree) agreed to vote any founder shares and any public shares held by them in favor of our initial
business combination. As a result, in addition to our sponsor’s founder shares, we would need 19,500,001, or 37.5%, of the 55,200,000 public shares sold in the IPO to be voted in favor of our initial business combination (assuming all issued
and outstanding shares are voted and the option to purchase additional units is not exercised) in order to have such initial business combination approved. Additionally, each public stockholder may elect to redeem its public shares without voting,
and if they do vote, irrespective of whether they vote for or against the proposed transaction. 
 Pursuant to our amended and restated
certificate of incorporation, if we are unable to complete our initial business combination within the completion window, we will: (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but no
more than ten business days thereafter, subject to lawfully available funds therefor, redeem the public shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (net of
permitted withdrawals and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the
right to receive further liquidating distributions, if any), subject to applicable law; and (3) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors,
dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Our sponsor, officers and directors have each entered into a letter agreement with
us, pursuant to which they have agreed to waive their rights to liquidating distributions from the trust account with respect to any founder shares held by them if we fail to complete our initial business combination within the completion window.
However, if our sponsor or any of our officers or directors acquires public shares after the IPO, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our initial
business combination within the completion window. 
 In the event of a liquidation, dissolution or winding up of the company after a
business combination, our stockholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of stock, if any, having preference over the
common stock. Our stockholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the common stock, except that we will provide our stockholders with the opportunity to redeem their public shares for
cash equal to their pro rata share of the aggregate amount on deposit in the trust account as of two business days prior to the consummation of our initial business combination, including interest (net of permitted withdrawals), upon the completion
of our initial business combination, subject to the limitations described herein. 
 Founder Shares 

The founder shares are identical to the shares of Class A common stock included in the units, except that: (1) only holders of the
founder shares have the right to vote on the election of directors prior to our initial business combination; provided, however, that with respect to the election of directors in connection with a meeting of the stockholders of the Company in which
a business combination is submitted to the stockholders of the Company for approval, holders of the Class A common stock and holders of the Class B common stock, voting together as a single class, shall have the exclusive right to vote for the
election of directors; (2) the founder shares are subject to certain transfer restrictions, as described in more detail below; (3) our sponsor, officers and directors have each entered into a letter agreement with us, pursuant to which
they have agreed to: (a) waive their redemption rights with respect to any founder shares and any public shares held by them in connection with the completion of our initial business combination, (b) waive their redemption rights with
respect to any founder shares and public shares held by them in connection with a stockholder vote to approve an amendment to our amended and restated certificate of incorporation to modify the substance or timing of our obligation to provide for
the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we have not consummated our initial business combination within the 

  
 3 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

 
completion window; and (c) waive their rights to liquidating distributions from the trust account with respect to any founder shares held by them if we fail to complete our initial business
combination within the completion window (although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within the completion
window); (4) the founder shares are automatically convertible into shares of our Class A common stock at the time of our initial business combination on a
one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described herein; and (5) the holders of founder shares are entitled to
registration rights. If we submit our initial business combination to our public stockholders for a vote, our sponsor, officers and directors have agreed (and their permitted transferees, as applicable, will agree) to vote any founder shares and any
public shares held by them in favor of our initial business combination. 
 The shares of Class B common stock will automatically
convert into shares of Class A common stock at the time of our initial business combination on a one-for-one basis, subject to adjustment as provided herein. In the
case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the IPO and related to the closing of our initial business combination, the ratio at which shares of
Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such anti-dilution adjustment with respect to
any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an
as-converted basis, 20% of the total number of all shares of common stock outstanding plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with our
initial business combination (net of the number of shares of Class A common stock redeemed in connection with our initial business combination), excluding any shares or equity-linked securities issued, or to be issued, to any seller in our
initial business combination and any private placement warrants issued upon the conversion of working capital loans made to us. 
 With
certain limited exceptions, the founder shares are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with our sponsor and other permitted transferees, each of whom are subject to
the same transfer restrictions) until the earlier of  (A) one year after the completion of our initial business combination, (B) subsequent to our initial business combination, if the closing price of our Class A common stock
equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least
150 days after our initial business combination, and (C) following the completion of our initial business combination, such future date on which we complete a liquidation, merger, stock exchange, reorganization or other similar transaction that
results in all of our public stockholders having the right to exchange their shares of common stock for cash, securities or other property. 

Preferred Stock 

Our amended and restated certificate of incorporation authorizes 1,000,000 shares of preferred stock and provides that shares of preferred
stock may be issued from time to time in one or more series. Our board of directors are authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any
qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our board of directors are able to, without stockholder approval, issue preferred stock with voting and other rights that could adversely affect the
voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of our board of directors to issue preferred stock without stockholder approval could have the effect of delaying, deferring or
preventing a change of control of us or the removal of existing management. We have no preferred stock outstanding at the date hereof. Although we do not currently intend to issue any shares of preferred stock, we cannot assure you that we will not
do so in the future. 

  
 4 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

 Warrants 

Public Stockholders’ Warrants 

Each whole warrant entitles the registered holder to purchase one share of our Class A common stock at a price of  $11.50 per share,
subject to adjustment as discussed below, at any time commencing on the later of 12 months from the closing of the IPO and 30 days after the completion of our initial business combination. Pursuant to the warrant agreement, a warrant holder may
exercise its warrants only for a whole number of shares of Class A common stock. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants have been issued upon separation of the units and only
whole warrants are traded. Accordingly, unless you purchase at least five units, you will not be able to receive or trade a whole warrant. The warrants will expire five years after the completion of our initial business combination, at 5:00 p.m.,
New York City time, or earlier upon redemption or liquidation. 
 We will not be obligated to deliver any shares of Class A common
stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act of 1933, as amended, (the “Securities Act”) covering the issuance of the
shares of Class A common issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to our satisfying our obligations described below with
respect to registration. No warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is
registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a
warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a
unit containing such warrant will have paid the full purchase price for the unit solely for the share of Class A common stock underlying such unit. 

We have agreed that as soon as practicable, but in no event later than 15 business days after the closing of our initial business combination,
we will use our reasonable best efforts to file with the SEC, and within 60 business days following our initial business combination to have declared effective, a registration statement covering the issuance of the shares of Class A common
stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if our Class A common stock is at the
time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of
public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration
statement, but will use our reasonable best efforts to qualify the shares under applicable blue sky laws to the extent an exemption is not available. 

Redemption of Warrants for Cash. Once the warrants become exercisable, we may call the warrants for redemption: 

 

	 	•	 	 in whole and not in part; 

 

	 	•	 	 at a price of  $0.01 per warrant; 

 

	 	•	 	 upon a minimum of 30 days’ prior written notice of redemption, or the
30-day redemption period, to each warrant holder; and 

  

	 	•	 	 if, and only if, the closing price of our Class A common stock equals or exceeds $18.00 per share (as
adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we
send the notice of redemption to the warrant holders. 

 If and when the warrants become redeemable by us, we may exercise
our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. 

We have established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call
a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled
redemption date. However, the price of the Class A common stock may fall below the $18.00 redemption trigger price as well as the $11.50 warrant exercise price after the redemption notice is issued. 

  
 5 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

 Redemption Procedures and Cashless Exercise. If we call the warrants for
redemption as described above, our management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a
“cashless basis,” our management will consider, among other factors, our cash position, the number of warrants that are outstanding and the dilutive effect on our stockholders of issuing the maximum number of shares of Class A common
stock issuable upon the exercise of our warrants. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the
product of the number of shares of Class A common stock underlying the warrants, multiplied by the excess of the “fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The
“fair market value” shall mean the average closing price of the Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If
our management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Class A common stock to be received upon exercise of the warrants, including the “fair
market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. We believe this feature is an attractive option to us if we
do not need the cash from the exercise of the warrants after our initial business combination. If we call our warrants for redemption and our management does not take advantage of this option, our sponsor and its permitted transferees would still be
entitled to exercise their private placement warrants for cash or on a cashless basis using the same formula described above that other warrant holders would have been required to use had all warrant holders been required to exercise their warrants
on a cashless basis, as described in more detail below. 
 A holder of a warrant may notify us in writing in the event it elects to be
subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual
knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) of the shares of Class A common stock outstanding immediately after giving effect to such exercise. 

Anti-Dilution Adjustments. If the number of outstanding shares of Class A common stock is increased by a stock dividend
payable in shares of Class A common stock, or by a split-up of shares of Class A common stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares of Class A common stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding shares of Class A common
stock. A rights offering to holders of Class A common stock entitling holders to purchase shares of Class A common stock at a price less than the fair market value will be deemed a stock dividend of a number of shares of Class A
common stock equal to the product of  (1) the number of shares of Class A common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or
exercisable for Class A common stock) multiplied by (2) one minus the quotient of (x) the price per share of Class A common stock paid in such rights offering divided by (y) the fair market value. For these purposes
(1) if the rights offering is for securities convertible into or exercisable for Class A common stock, in determining the price payable for Class A common stock, there will be taken into account any consideration received for such
rights, as well as any additional amount payable upon exercise or conversion and (2) fair market value means the volume weighted average price of Class A common stock as reported during the ten trading day period ending on the trading day
prior to the first date on which the shares of Class A common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights. 

In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or
other assets to the holders of Class A common stock on account of such shares of Class A common stock (or other shares of our capital stock into which the warrants are convertible), other than (a) as described above, (b) certain
ordinary cash dividends, (c) to satisfy the redemption rights of the holders of Class A common stock in connection with a proposed initial business combination, (d) to satisfy the redemption rights of the holders of Class A
common stock in connection with a stockholder vote to amend our amended and restated certificate of incorporation to modify the substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial
business combination or to redeem 100% of our Class A common stock if 

  
 6 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

 
we do not complete our initial business combination within the completion window, or (e) in connection with the redemption of our public shares upon our failure to complete our initial
business combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of
Class A common stock in respect of such event. 
 If the number of outstanding shares of our Class A common stock is decreased by
a consolidation, combination, reverse stock split or reclassification of shares of Class A common stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar
event, the number of shares of Class A common stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding shares of Class A common stock. 

Whenever the number of shares of Class A common stock purchasable upon the exercise of the warrants is adjusted, as described above, the
warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of shares of Class A common stock purchasable upon the
exercise of the warrants immediately prior to such adjustment, and (y) the denominator of which will be the number of shares of Class A common stock so purchasable immediately thereafter. 

In case of any reclassification or reorganization of the outstanding shares of Class A common stock (other than those described above or
that solely affects the par value of such shares of Class A common stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing corporation and
that does not result in any reclassification or reorganization of our outstanding shares of Class A common stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or
substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the
shares of our Class A common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon
such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such
event. However, if such holders were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for
which each warrant will become exercisable will be deemed to be the weighted average of the kind and amount received per share by such holders in such consolidation or merger that affirmatively make such election, and if a tender, exchange or
redemption offer has been made to and accepted by such holders (other than a tender, exchange or redemption offer made by the company in connection with redemption rights held by stockholders of the company as provided for in the company’s
amended and restated certificate of incorporation or as a result of the redemption of shares of Class A common stock by the company if a proposed initial business combination is presented to the stockholders of the company for approval) under
circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such
maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of which any such affiliate or associate
is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the outstanding shares of Class A common stock, the holder of a warrant will be entitled to receive
the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such warrant holder had exercised the warrant prior to the expiration of such tender or exchange offer, accepted such
offer and all of the Class A common stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as
possible to the adjustments provided for in the warrant agreement. Additionally, if less than 70% of the consideration receivable by the holders of Class A common stock in such a transaction is payable in the form of common stock in the
successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading
or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the
warrant agreement based on the per share consideration minus Black-Scholes Warrant Value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to

  
 7 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

 
holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full
potential value of the warrants in order to determine and realize the option value component of the warrant. This formula is to compensate the warrant holder for the loss of the option value portion of the warrant due to the requirement that the
warrant holder exercise the warrant within 30 days of the event. The Black-Scholes model is an accepted pricing model for estimating fair market value where no quoted market price for an instrument is available. 

The warrants have been issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as
warrant agent, and us. The warrant agreement has been filed as an exhibit to the IPO registration statement and contains the description of the terms and conditions applicable to the warrants. The warrant agreement provides that the terms of the
warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the then outstanding public warrants to make any change that adversely
affects the interests of the registered holders of public warrants. 
 The warrants may be exercised upon surrender of the warrant
certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a
cashless basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders do not have the rights or privileges of holders of Class A common stock and any voting rights
until they exercise their warrants and receive shares of Class A common stock. After the issuance of shares of Class A common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on
all matters to be voted on by stockholders. 
 Private Placement Warrants 

The private placement warrants (including the Class A common stock issuable upon exercise of the private placement warrants) will not be
transferable, assignable or salable until 30 days after the completion of our initial business combination (except, among other limited exceptions as described under the IPO registration statement’s section entitled “Principal
Stockholders — Transfers of Founder Shares and Private Placement Warrants,” to our officers and directors and other persons or entities affiliated with our sponsor) and they will not be redeemable by us so long as they are held
by our sponsor or its permitted transferees. Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis and are entitled to certain registration rights. Otherwise, the private placement
warrants have terms and provisions that are identical to those of the warrants sold as part of the units in the IPO. If the private placement warrants are held by holders other than our sponsor or its permitted transferees, the private placement
warrants will be redeemable by us and exercisable by the holders on the same basis as the warrants included in the units sold in the IPO. 

If holders of the private placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering
their warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the excess of the
“fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the average closing price of the Class A common stock for the 10 trading days
ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. The reason that we have agreed that these warrants will be exercisable on a cashless basis so long as they are held by our
sponsor and its permitted transferees is because it is not known at this time whether they will be affiliated with us following a business combination. If they remain affiliated with us, their ability to sell our securities in the open market will
be significantly limited. We expect to have policies in place that prohibit insiders from selling our securities except during specific periods of time. Even during such periods of time when insiders will be permitted to sell our securities, an
insider cannot trade in our securities if he or she is in possession of material non-public information. Accordingly, unlike public stockholders who could exercise their warrants and sell the shares of
Class A common stock received upon such exercise freely in the open market in order to recoup the cost of such exercise, the insiders could be significantly restricted from selling such securities. As a result, we believe that allowing the
holders to exercise such warrants on a cashless basis is appropriate. 

  
 8 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

 In order to finance transaction costs in connection with an intended initial business
combination, our sponsor, an affiliate of our sponsor or our officers and directors may, but none of them is obligated to, loan us funds as may be required. If we complete our initial business combination, we would repay such loaned amounts out of
the proceeds of the trust account released to us. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our
trust account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into warrants at a price of  $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement
warrants issued to our sponsor. 
 Dividends 

We have not paid any cash dividends on our common stock to date and do not intend to pay cash dividends prior to the completion of our initial
business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination. The
payment of any cash dividends subsequent to a business combination will be within the discretion of our board of directors at such time. In addition, our board of directors is not currently contemplating and does not anticipate declaring any stock
dividends in the foreseeable future. Further, if we incur any indebtedness, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith. 

Our Transfer Agent and Warrant Agent 

The transfer agent for our common stock and warrant agent for our warrants is Continental Stock Transfer & Trust Company. We have
agreed to indemnify Continental Stock Transfer & Trust Company in its roles as transfer agent and warrant agent, its agents and each of its stockholders, directors, officers and employees against all liabilities, including judgments, costs
and reasonable counsel fees that may arise out of acts performed or omitted for its activities in that capacity, except for any liability due to any gross negligence, willful misconduct or bad faith of the indemnified person or entity. 

Our Amended and Restated Certificate of Incorporation 

Our amended and restated certificate of incorporation contains certain requirements and restrictions from the time of the IPO that will apply
to us until the completion of our initial business combination. These provisions (other than amendments relating to the appointment of directors, which require the approval of a majority of the Class B common stock then outstanding) cannot be
amended without the approval of the holders of at least 65% of our common stock. Our sponsor, who collectively and beneficially own 20% of our common stock, may participate in any vote to amend our amended and restated certificate of incorporation
and has the discretion to vote in any manner it chooses. Prior to an initial business combination, we may not issue additional securities that can vote on amendments to our amended and restated certificate of incorporation. Specifically, our amended
and restated certificate of incorporation provides, among other things, that: 
  

	 	•	 	 if we are unable to complete our initial business combination within the completion window, we will:
(1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than ten business days thereafter, subject to lawfully available funds therefor, redeem 100% of the public shares, at a per
share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (net of permitted withdrawals and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding
public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law; and (3) as promptly as reasonably
possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the
requirements of other applicable law; 

  
 9 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

	 	•	 	 prior to our initial business combination, we may not issue additional shares of capital stock that would entitle
the holders thereof to: (1) receive funds from the trust account; or (2) vote on any initial business combination; 

  

	 	•	 	 although we do not intend to enter into a business combination with a target business that is affiliated with M.
Klein and Company, our sponsor, our directors or our officers, we are not prohibited from doing so. In the event we seek to complete our initial business combination with a company that is affiliated with M. Klein and Company, our sponsor, officers
or directors, we, or a committee of independent and disinterested directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA or from an independent accounting firm that such a business combination is fair
to our company from a financial point of view; 

  

	 	•	 	 if a stockholder vote on our initial business combination is not required by applicable law or stock exchange
rules and we do not decide to hold a stockholder vote for business or other reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file
tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under
Regulation 14A of the Exchange Act; 

  

	 	•	 	 if required by applicable stock-exchange rules, our initial business combination must be with one or more
operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the trust account (excluding the amount of any deferred underwriting discount). 

 

	 	•	 	 if our stockholders approve an amendment to our amended and restated certificate of incorporation to modify the
substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within the
completion window, we will provide our public stockholders with the opportunity to redeem all or a portion of their shares of common stock upon such approval at a per share price, payable in cash, equal to the aggregate amount then on deposit in the
trust account, including interest (net of permitted withdrawals), divided by the number of then outstanding public shares; and 

  

	 	•	 	 we will not effectuate our initial business combination with another blank check company or a similar company
with nominal operations. 

 In addition, our amended and restated certificate of incorporation provides that under no
circumstances will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that we do not then become subject to the SEC’s “penny stock” rules) or any greater net tangible asset
or cash requirement which may be contained in the agreement relating to our initial business combination. 
 Certain Anti-Takeover
Provisions of Delaware Law and our Amended and Restated Certificate of Incorporation and Bylaws 
 We have elected to be exempt from
the restrictions imposed under Section 203 of the DGCL. However, our certificate of incorporation contains similar provisions providing that we may not engage in certain “business combinations” with any “interested
stockholder” for a three-year period following the time that such stockholder becomes an interested stockholder unless: 
  

	 	•	 	 prior to such time, our board of directors approved either the business combination or the transaction which
resulted in the stockholder becoming an interested stockholder; 

  

	 	•	 	 upon consummation of the transaction which resulted in the stockholder becoming an “interested
stockholder,” the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced (excluding certain shares); or 

  
 10 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

	 	•	 	 on or subsequent to such time, the business combination is approved by the Board and authorized at an annual or
special meeting of stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested stockholder. 

Generally, a “business combination” includes a merger, asset or stock sale to the interested stockholder. Subject to certain
exceptions, an “interested stockholder” is a person who, together with that person’s affiliates and associates, owns, or within the previous three years owned, 15% or more of our voting stock. 

Under some circumstances, this provision will make it more difficult for a person who is an interested stockholder to effect various business
combinations with us for a three-year period. 
 Our certificate of incorporation provides that our sponsor and its various affiliates,
successors and transferees will not be deemed to be “interested stockholders” regardless of the percentage of our voting stock owned by them, and accordingly will not be subject to this provision. 

Our authorized but unissued common stock and preferred stock are available for future issuances without stockholder approval and could be
utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render more
difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise. 

Exclusive Forum For Certain Lawsuits 

Our amended and restated certificate of incorporation requires, to the fullest extent permitted by law, that (i) any derivative action or
proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee to us or our stockholders, (iii) any action asserting a claim against us, our directors,
officers or employees arising pursuant to any provision of the DGCL or our amended and restated certificate of incorporation or bylaws, or (iv) any action asserting a claim against us, our directors, officers or employees governed by the
internal affairs doctrine may be brought only in the Court of Chancery in the State of Delaware, except any action (A) as to which the Court of Chancery of the State of Delaware determines that there is an indispensable party not subject to the
jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court or
forum other than the Court of Chancery, (C) for which the Court of Chancery does not have subject matter jurisdiction, or (D) arising under the Securities Act, as to which the Court of Chancery and the federal district court for the
District of Delaware shall have concurrent jurisdiction. If an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder’s counsel. Although we believe
this provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is enforceable, the
provision may have the effect of discouraging lawsuits against our directors and officers, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder. 

Our amended and restated certificate of incorporation provides that the exclusive forum provision will be applicable to the fullest extent
permitted by applicable law. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the
exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Section 22 of the Securities Act creates
concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. As noted above, our amended and restated certificate of incorporation
provides that the Court of Chancery and the federal district court for the District of Delaware shall have concurrent jurisdiction over any action arising under the Securities Act. Accordingly, there is uncertainty as to whether a court would
enforce such provision, and our stockholders will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder. 

  
 11 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

 Special Meeting of Stockholders 

Our bylaws provide that special meetings of our stockholders may be called only by a majority vote of our board of directors, by our chief
executive officer or by our chairman, if any. 
 Advance Notice Requirements for Stockholder Proposals and Director Nominations

 Our bylaws provide for advance notice procedures with respect to stockholder proposals and the nomination of candidates for
election as directors, other than nominations made by or at the direction of our board of directors or a committee of our board of directors. In order for any matter to be “properly brought” before a meeting, a stockholder will have to
comply with advance notice requirements and provide us with certain information. Generally, to be timely, a stockholder’s notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first
anniversary date of the immediately preceding annual meeting of stockholders. Pursuant to Rule 14a-8 of the Exchange Act, proposals seeking inclusion in our annual proxy statement must comply with the notice
periods contained therein. Our bylaws also specify requirements as to the form and content of a stockholder’s notice. Our bylaws allow the chairman of the meeting at a meeting of the stockholders to adopt rules and regulations for the conduct
of meetings which may have the effect of precluding the conduct of certain business at a meeting if the rules and regulations are not followed. These provisions may also defer, delay or discourage a potential acquirer from conducting a solicitation
of proxies to elect the acquirer’s own slate of directors or otherwise attempting to influence or obtain control of us. 
 Action
by Written Consent 
 Any action required or permitted to be taken by our stockholders must be effected by a duly called annual or
special meeting of such stockholders and may not be effected by written consent of the stockholders other than with respect to our Class B common stock. 

Classified Board of Directors 

Our board of directors will initially be divided into three classes, Class I, Class II and Class III, with members of each
class serving staggered three-year terms. Our amended and restated certificate of incorporation provides that the authorized number of directors may be changed only by resolution of the board of directors. Subject to the terms of any preferred
stock, any or all of the directors may be removed from office at any time, with or without cause by the affirmative vote of holders of a majority of the voting power of all then outstanding shares of our Class B common stock entitled to vote
generally in the election of directors, voting together as a single class. Any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of a majority of our directors
then in office. 
 Class B Common Stock Consent Right 

For so long as any shares of Class B common stock remain outstanding, we may not, without the prior vote or written consent of the
holders of a majority of the shares of Class B common stock then outstanding, voting separately as a single class, amend, alter or repeal any provision of our certificate of incorporation, whether by merger, consolidation or otherwise, if such
amendment, alteration or repeal would alter or change the powers, preferences or relative, participating, optional or other or special rights of the Class B common stock. Any action required or permitted to be taken at any meeting of the
holders of Class B common stock may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of the outstanding Class B
common stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares of Class B common stock were present and voted. 

  
 12 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

 Securities Eligible for Future Sale 

We have 55,200,000 shares of Class A common stock outstanding. All of these shares are freely tradable without restriction or further
registration under the Securities Act, except for any shares purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of the 13,800,000 Class B founder shares and all 14,040,000 private placement warrants
are restricted securities under Rule 144, in that they were issued in private transactions not involving a public offering, and are subject to transfer restrictions as set forth in the IPO prospectus. 

Rule 144 

Pursuant to Rule 144, a person who has beneficially owned restricted shares of our common stock or warrants for at least six months would be
entitled to sell their securities provided that: (1) such person is not deemed to have been one of our affiliates at the time of, or at any time during the three months preceding, a sale; and (2) we are subject to the Exchange Act periodic
reporting requirements for at least three months before the sale and have filed all required reports under Section 13 or 15(d) of the Exchange Act during the 12 months (or such shorter period as we were required to file reports) preceding the
sale. 
 Persons who have beneficially owned restricted shares of our common stock or warrants for at least six months but who are our
affiliates at the time of, or at any time during the three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not
exceed the greater of: 
  

	 	•	 	 1% of the total number of shares of Class A common stock then outstanding, which will equal 552,000 shares;
or 

  

	 	•	 	 the average weekly reported trading volume of the common stock during the four calendar weeks preceding the
filing of a notice on Form 144 with respect to the sale. 

 Sales by our affiliates under Rule 144 are also limited by
manner of sale provisions and notice requirements and to the availability of current public information about us. 
 Restrictions on
the Use of Rule 144 by Shell Companies or Former Shell Companies 
 Rule 144 is not available for the resale of securities initially
issued by shell companies (other than a business combination related shell companies) or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following
conditions are met: 
  

	 	•	 	 the issuer of the securities that was formerly a shell company has ceased to be a shell company;

  

	 	•	 	 the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange
Act; 

  

	 	•	 	 the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable,
during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form 8-K; and 

 

	 	•	 	 at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC
reflecting its status as an entity that is not a shell company. 

 As a result, our sponsor will be able to sell its
founder shares and private placement warrants, as applicable, pursuant to Rule 144 without registration one year after we have completed our initial business combination. 

Registration Rights 

The holders of the founder shares, private placement warrants and warrants that may be issued upon conversion of working capital loans (and
any shares of common stock issuable upon the exercise of the private placement warrants or warrants issued upon conversion of the working capital loans and upon conversion of the founder shares) will be entitled to registration rights pursuant to a
registration rights agreement requiring us to register such securities for resale (in the case of the founder shares, only after conversion into shares of Class A 

  
 13 

 CHURCHILL CAPITAL CORP VI 

DECEMBER 31, 2021 
  

 
common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that we register such securities. In addition, the holders
have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination and rights to require us to register for resale such securities pursuant to Rule
415 under the Securities Act. We will bear the expenses incurred in connection with the filing of any such registration statement. 

Listing of Securities 

We have listed our units, Class A common stock and warrants on the NYSE under the symbols “CCVI.U,” “CCVI” and
“CCVI WS,” respectively. The common stock and warrants constituting the units began separate trading on April 5, 2021. 

  
 14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]